| Bioactivity | rel-Levormeloxifene (rel-L-Centchroman) is the relative configuration of Levormeloxifene (HY-122359). rel-Levormeloxifene is a selective estrogen receptor modulator (SERM). rel-Levormeloxifene inhibits proliferation of leukemia cells with IC50 about 7 μM, arrests cell cycle at G0/G1 phase, and induces apoptosis. rel-Levormeloxifene induces differentation of myelogenesis leukemia, and enhances ROS production in K562 cells[1]. |
| CAS | 31477-60-8 |
| Formula | C30H35NO3 |
| Molar Mass | 457.60 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Pooja PAL, et al., An anti-leukemic agent useful for inducing differentiation in myeloid leukemia cells. WO2015044950. |
rel-Levormeloxifene
CAS: 31477-60-8 F: C30H35NO3 W: 457.60
rel-Levormeloxifene (rel-L-Centchroman) is the relative configuration of Levormeloxifene (HY-122359). rel-Levormeloxifen
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.